US Bancorp’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.62K | Buy |
1,495
+44
| +3% | +$136 | ﹤0.01% | 3658 |
|
|
2025
Q1 | $5.06K | Sell |
1,451
-294
| -17% | -$1.03K | ﹤0.01% | 3642 |
|
|
2024
Q4 | $5.71K | Sell |
1,745
-468
| -21% | -$1.53K | ﹤0.01% | 3607 |
|
|
2024
Q3 | $8.52K | Sell |
2,213
-855
| -28% | -$3.29K | ﹤0.01% | 3408 |
|
|
2024
Q2 | $9.48K | Buy |
3,068
+1,617
| +111% | +$5K | ﹤0.01% | 3317 |
|
|
2024
Q1 | $3.74K | Buy |
+1,451
| New | +$3.74K | ﹤0.01% | 3580 |
|
|
2023
Q4 | – | Sell |
-1,909
| Closed | -$3.88K | – | 3939 |
|
|
2023
Q3 | $3.88K | Hold |
1,909
| – | – | ﹤0.01% | 3493 |
|
|
2023
Q2 | $4.39K | Buy |
+1,909
| New | +$4.39K | ﹤0.01% | 3481 |
|
|
2022
Q1 | – | Sell |
-475
| Closed | -$2K | – | 4015 |
|
|
2021
Q4 | $2K | Buy |
+475
| New | +$2K | ﹤0.01% | 3829 |
|
|
2017
Q3 | – | Sell |
-200
| Closed | -$1K | – | 3558 |
|
|
2017
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 3442 |
|
|
2017
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 3445 |
|
|
2016
Q4 | $0 | Sell |
200
-50
| -20% | – | ﹤0.01% | 3527 |
|
|
2016
Q3 | $1K | Hold |
250
| – | – | ﹤0.01% | 3421 |
|
|
2016
Q2 | $1K | Sell |
250
-50
| -17% | -$200 | ﹤0.01% | 3455 |
|
|
2016
Q1 | $1K | Hold |
300
| – | – | ﹤0.01% | 3425 |
|
|
2015
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 3501 |
|
|
2015
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 3412 |
|
|
2015
Q2 | $4K | Buy |
300
+100
| +50% | +$1.33K | ﹤0.01% | 3320 |
|
|
2015
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 3372 |
|
|
2014
Q4 | $3K | Buy |
+200
| New | +$3K | ﹤0.01% | 3360 |
|